C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 34.44 CNY 0.06% Market Closed
Market Cap: 26B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

China National Medicines Corp Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China National Medicines Corp Ltd
Operating Income Peer Comparison

Comparables:
1099
601607
600998
000963
Q
301015

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
Operating Income
ÂĄ2.4B
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
18%
Sinopharm Group Co Ltd
HKEX:1099
Operating Income
ÂĄ20.8B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
11%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Operating Income
ÂĄ8.5B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Operating Income
ÂĄ4B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
16%
Huadong Medicine Co Ltd
SZSE:000963
Operating Income
ÂĄ3.9B
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
12%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Operating Income
ÂĄ903.5m
CAGR 3-Years
30%
CAGR 5-Years
22%
CAGR 10-Years
N/A

See Also

What is China National Medicines Corp Ltd's Operating Income?
Operating Income
2.4B CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's Operating Income amounts to 2.4B CNY.

What is China National Medicines Corp Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
18%

Over the last year, the Operating Income growth was 1%. The average annual Operating Income growth rates for China National Medicines Corp Ltd have been 9% over the past three years , 3% over the past five years , and 18% over the past ten years .

Back to Top